Bio-Techne (TECH) operating cash flow was $292M in FY2026 (+2% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2026
$292M
+2%
2025
$288M
-4%
2024
$299M
+18%
2023
$254M
-22%
2022
$325M
-8%
2021
$352M
+72%
2020
$205M
+13%
2019
$182M
+7%
2018
$170M
+19%
2017
$144M
-0%
2016
$144M
+3%
2015
$139M
+2%
2014
$137M
+11%
2013
$124M
-3%
2012
$127M
-0%
2011
$127M
+14%
2010
$111M
-0%
2009
$111M
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$95M
Q1 2026
$87M
Q4 2025
$82M
Q3 2025
$28M
Q2 2025
$98M
Q1 2025
$41M
Q4 2024
$84M
Q3 2024
$64M
Q2 2024
$75M
Q1 2024
$81M
Q4 2023
$83M
Q3 2023
$59M
Source: TECH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.